International Women’s Day Spotlight
Building a more inclusive future in HealthTech
How can we ensure the HealthTech sector promotes a culture that is diverse, equitable, and inclusive? As part of International Women’s Day, CSJ invited some top female HealthTech leaders to share their views on why diversity matters in the sector, their leadership vision for the future, and how we can encourage the next generation of women to drive innovation forward in this field.
Fostering an inclusive culture is fundamental to the success of the HealthTech sector. Ensuring that every voice is heard, respected, and valued helps create an industry that attracts and nurtures diverse talent, while developing technologies and services that meet the needs of all communities. Equality goes beyond representation; it
requires addressing systemic barriers and driving meaningful change. Tackling health inequalities has become a key priority for both the NHS and the HealthTech community. To lead efforts in this critical area, ABHI established its Health Inequalities Group in 2025, with a particular focus on Women’s Health, recognising the significant opportunities to improve outcomes in this area.
Dr. Nina Wilson, Clinical Advisor to ABHI since 2024, has played a central role in shaping these initiatives. “Women’s health has been historically overlooked, yet addressing these
disparities presents an opportunity to improve outcomes not just for women but for all communities. By ensuring that research reflects sex-specific needs and fostering collaboration between the clinical community and industry, we can deliver more equitable solutions. Leaders from all walks of life will be crucial in driving this progress.” Dr. Wilson explains. On International Women’s Day, several female leaders from ABHI’s member network shared
their thoughts on leadership, diversity, and the steps needed to create a more inclusive HealthTech sector.
Stephanie Bolton is the Global President of LivaNova’s epilepsy business, a role in which she oversees strategy, R&D, manufacturing, operations, team development, and therapy advancement
worldwide. While her career began in the pharmaceutical industry, she has dedicated the past 14 years to LivaNova. Stephanie started working in the field with the company’s VNS Therapy System, which treats epilepsy. Her commitment to patient-centred innovation and
Female professionals bring unique perspectives that drive innovation, particularly in areas like FemTech. Their leadership ensures solutions are inclusive and meet the diverse needs of patients.
leadership has made a significant impact on advancing epilepsy care globally. “As a global leader in healthcare technology, I am acutely aware of the role HealthTech plays, in collaboration with healthcare providers and institutions, in driving positive long-term health outcomes. With a clear vision for patient- centred innovation, we can transform care delivery and improve outcomes for all. “My vision for the HealthTech sector is
anchored in three core areas: equitable access for all, systems transformation through technology and innovation, and environmental sustainability. Leaders must adopt bold, innovative strategies to foster growth, efficiency, and patient-centric care. A vision is not just about aspirations; it is about actionable steps that enable healthcare organisations to achieve long-term, meaningful change. “I am passionate about creating a workplace
culture where all genders thrive, in an organisation with diversity and inclusion at its heart. Diversity is not just a social imperative – it is a business imperative,” Stephanie comments. She highlights a study by Boston Consulting Group which found that companies with above-
March 2025 I
www.clinicalservicesjournal.com 31
LuxeShutter24/
peopleimages.com -
stock.adobe.com
t
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
